Shandong Rike ChemicalLTD Past Earnings Performance
Past criteria checks 0/6
Shandong Rike ChemicalLTD's earnings have been declining at an average annual rate of -5.3%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 4.6% per year. Shandong Rike ChemicalLTD's return on equity is 2.3%, and it has net margins of 2.3%.
Key information
-5.3%
Earnings growth rate
-6.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 4.6% |
| Return on equity | 2.3% |
| Net Margin | 2.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Shandong Rike ChemicalLTD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,561 | 58 | 98 | 36 |
| 31 Dec 23 | 2,538 | 85 | 81 | 41 |
| 30 Sep 23 | 2,535 | 118 | 80 | 22 |
| 31 Mar 23 | 2,607 | 133 | 83 | 46 |
| 31 Dec 22 | 2,760 | 196 | 83 | 40 |
| 30 Sep 22 | 2,951 | 217 | 82 | 49 |
| 31 Mar 22 | 2,930 | 233 | 85 | 27 |
| 01 Jan 22 | 2,773 | 190 | 87 | 24 |
| 30 Sep 21 | 2,546 | 160 | 56 | 28 |
| 30 Jun 21 | 2,424 | 169 | 53 | 17 |
| 31 Mar 21 | 2,359 | 189 | 55 | 15 |
| 31 Dec 20 | 2,275 | 207 | 70 | 14 |
| 30 Sep 20 | 2,377 | 241 | 129 | 12 |
| 30 Jun 20 | 2,441 | 225 | 142 | 11 |
| 31 Mar 20 | 2,407 | 208 | 151 | 11 |
| 31 Dec 19 | 2,420 | 178 | 143 | 12 |
| 30 Sep 19 | 2,266 | 134 | 130 | 12 |
| 30 Jun 19 | 2,139 | 115 | 127 | 11 |
| 31 Mar 19 | 1,884 | 94 | 113 | 10 |
| 31 Dec 18 | 1,569 | 103 | 116 | 10 |
| 30 Sep 18 | 1,583 | 104 | 113 | 24 |
| 30 Jun 18 | 1,689 | 117 | 114 | 22 |
| 31 Mar 18 | 1,894 | 121 | 125 | 19 |
| 31 Dec 17 | 2,103 | 95 | 125 | 17 |
| 30 Sep 17 | 1,992 | 91 | 123 | 0 |
| 30 Jun 17 | 1,784 | 72 | 123 | 0 |
| 31 Mar 17 | 1,631 | 73 | 119 | 0 |
| 31 Dec 16 | 1,547 | 80 | 119 | 0 |
| 30 Sep 16 | 1,431 | 92 | 113 | 0 |
| 30 Jun 16 | 1,386 | 102 | 113 | 0 |
| 31 Mar 16 | 1,425 | 100 | 120 | 0 |
| 31 Dec 15 | 1,423 | 107 | 120 | 0 |
| 30 Sep 15 | 1,466 | 97 | 127 | 0 |
| 30 Jun 15 | 1,477 | 80 | 123 | 0 |
| 31 Mar 15 | 1,385 | 64 | 115 | 0 |
| 31 Dec 14 | 1,305 | 53 | 107 | 0 |
| 30 Sep 14 | 1,216 | 43 | 107 | 0 |
| 30 Jun 14 | 1,077 | 45 | 101 | 0 |
| 31 Mar 14 | 1,008 | 55 | 103 | 0 |
| 31 Dec 13 | 1,002 | 55 | 108 | 0 |
| 30 Sep 13 | 968 | 54 | 114 | 0 |
| 30 Jun 13 | 1,017 | 66 | 119 | 0 |
Quality Earnings: 300214 has a high level of non-cash earnings.
Growing Profit Margin: 300214's current net profit margins (2.3%) are lower than last year (5.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300214's earnings have declined by 5.3% per year over the past 5 years.
Accelerating Growth: 300214's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300214 had negative earnings growth (-56.3%) over the past year, making it difficult to compare to the Chemicals industry average (-20.1%).
Return on Equity
High ROE: 300214's Return on Equity (2.3%) is considered low.